341
Views
17
CrossRef citations to date
0
Altmetric
Original Research

Asthma impacts on workplace productivity in employed patients who are symptomatic despite background therapy: a multinational survey

, , , , , , , & show all
Pages 183-194 | Published online: 11 Jul 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

J. P. M. van der Valk, P. P. Hekking, S. P. Rauh, K. W. Patberg, I. A. van Veen, A. Van Huisstede, F. W. J. M. Smeenk, M. J. T. van de Ven, M. E. A. C. Broeders, B. Hilvering, J. van Exsel, K. T. M. Oud, B. Langeveld, K. B. Fieten, A. van Veen, S. Hashimoto, J. K. Sont, A. ten Brinke & G. J. Braunstahl. (2023) Anti-IL-5/5Ra biologics improve work productivity and activity in severe asthma: a RAPSODI registry-based cohort study. Journal of Asthma 60:10, pages 1869-1876.
Read now
Kjell Erik Julius Håkansson, Vibeke Backer & Charlotte Suppli Ulrik. (2022) Disease Control, Not Severity, Drives Job Absenteeism in Young Adults with Asthma – A Nationwide Cohort Study. Journal of Asthma and Allergy 15, pages 827-837.
Read now
Jane Murphy, Gerard J. Molloy, Lisa Hynes & Jenny McSharry. (2022) Young adult preferences for digital health interventions to support adherence to inhaled corticosteroids in asthma: a qualitative study. Health Psychology and Behavioral Medicine 10:1, pages 557-578.
Read now
Adriel Shao En Ong, Adrian Kwok Wai Chan, Rehena Sultana & Mariko Siyue Koh. (2021) Impact of psychological impairment on quality of life and work impairment in severe asthma. Journal of Asthma 58:11, pages 1544-1553.
Read now
Giorgio Walter Canonica, Giorgio Lorenzo Colombo, Paola Rogliani, Pierachille Santus, Claudia Pitotti, Sergio Di Matteo, Chiara Martinotti & Giacomo Matteo Bruno. (2020) Omalizumab for Severe Allergic Asthma Treatment in Italy: A Cost-Effectiveness Analysis from PROXIMA Study. Risk Management and Healthcare Policy 13, pages 43-53.
Read now

Articles from other publishers (12)

Tomas Abbott, Carlos Balmaceda, Paula Zamorano, Andres Giglio & Manuel Espinoza. (2023) Cost-Effectiveness of Mepolizumab Add-On in the Treatment of Severe Eosinophilic Asthma in Chile. Value in Health Regional Issues 35, pages 69-77.
Crossref
Wei-Chiao Chang, Hanoch Livneh, Wei-Jen Chen, Chang-Cheng Hsieh, Yu-Han Wang, Ming-Chi Lu, How-Ran Guo & Tzung-Yi Tsai. (2022) Adding Chinese Herbal Medicine to Routine Care is Associated With a Lower Risk of Rheumatoid Arthritis Among Patients With Asthma: A Population-Based Retrospective Cohort Study. Frontiers in Pharmacology 13.
Crossref
Frank C. Albers, Daniel J. Bratton, Necdet B. Gunsoy, Sarah M. Cockle, Rafael Alfonso‐Cristancho & Gert‐Jan Braunstahl. (2022) Mepolizumab improves work productivity, activity limitation, symptoms, and rescue medication use in severe eosinophilic asthma. The Clinical Respiratory Journal 16:3, pages 252-258.
Crossref
Eusebi Chiner, Carme Hernández, Marina Blanco‐Aparicio, Eunice Funenga‐Fitas & Carlos Jiménez‐Ruiz. (2021) Patient perspectives of the influence of severe and non‐severe asthma on their quality of life: A national survey of asthma patients in Spain. The Clinical Respiratory Journal 16:2, pages 130-141.
Crossref
Josh Williams, Jari Kolehmainen, Steve Cunningham, Ali Ozel & Uwe Wolfram. (2022) Effect of patient inhalation profile and airway structure on drug deposition in image-based models with particle-particle interactions. International Journal of Pharmaceutics 612, pages 121321.
Crossref
Eli O. Meltzer, Robert S. Zeiger, Peter Dicpinigaitis, Jonathan A. Bernstein, John J. Oppenheimer, Nate A. Way, Vicky W. Li, Robert Boggs, Michael J. Doane, Eduardo Urdaneta, Jessica P. Weaver, Jonathan Schelfhout & Eileen Fonseca. (2021) Prevalence and Burden of Chronic Cough in the United States. The Journal of Allergy and Clinical Immunology: In Practice 9:11, pages 4037-4044.e2.
Crossref
Alvar Agusti, Neil Barnes, Alvaro A. Cruz, Peter G. Gibson, Liam G. Heaney, Hiromasa Inoue, David Leather, Fernando J. Martinez, Vanessa M. McDonald, John Oppenheimer, Alberto Papi, Ian D. Pavord, Mike Thomas, Samantha Walker & Louisa Yates. (2021) Moving towards a Treatable Traits model of care for the management of obstructive airways diseases. Respiratory Medicine 187, pages 106572.
Crossref
Jane Murphy, Jenny McSharry, Lisa Hynes & Gerard J Molloy. (2021) A Smartphone App to Support Adherence to Inhaled Corticosteroids in Young Adults With Asthma: Multi-Methods Feasibility Study. JMIR Formative Research 5:9, pages e28784.
Crossref
Nicolas Borchers-Arriagada, Penelope J. Jones, Andrew J. Palmer, Bonnie Bereznicki, Nick Cooling, Janet M. Davies & Fay H. Johnston. (2021) What are the health and socioeconomic impacts of allergic respiratory disease in Tasmania?. Australian Health Review 45:3, pages 281-289.
Crossref
Eric A Finkelstein, Eden Lau, Brett Doble, Bennett Ong & Mariko Siyue Koh. (2021) Economic burden of asthma in Singapore. BMJ Open Respiratory Research 8:1, pages e000654.
Crossref
Raf Aerts, Sebastien Dujardin, Benoit Nemery, An Van Nieuwenhuyse, Jos Van Orshoven, Jean-Marie Aerts, Ben Somers, Marijke Hendrickx, Nicolas Bruffaerts, Mariska Bauwelinck, Lidia Casas, Claire Demoury, Michelle Plusquin & Tim S. Nawrot. (2020) Residential green space and medication sales for childhood asthma: A longitudinal ecological study in Belgium. Environmental Research 189, pages 109914.
Crossref
Sassan Rajabi, Mojgan Sadat Aghvamy, Nasrin Bahraminejad & Ramezan Fallah. (2018) A Comparative Study of the Life Quality and Style of the Healthy and Asthma Suffering People Referring to Zanjan Province Hospitals. Preventive Care In Nursing and Midwifery Journal 8:3, pages 35-41.
Crossref